Effect of Finerenone on CKD-Associated Cardiovascular Risk in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
JAMA Cardiol 2023 Jun 14;[EPub Ahead of Print], R Agarwal, B Pitt, P Rossing, SD Anker, G Filippatos, LM Ruilope, CP Kovesdy, K Tuttle, M Vaduganathan, C Wanner, S Bansilal, M Gebel, A Joseph, R Lawatscheck, GL BakrisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.